免疫球蛋白治疗对艾曲波帕疗效差的难治性原发性免疫性血小板减少症2例被引量：2

导出

摘要原发性免疫性血小板减少症(ITP)的一线治疗药物为糖皮质激素,治疗不佳者可行脾切除,若仍治疗无效为难治性ITP。艾曲波帕是口服的血小板生成素受体激动药,美国食品药品监督管理局批准用于治疗对糖皮质激素、脾切除反应不佳的慢性ITP患者[1]。艾曲波帕常规用法为空腹(饭前1小时或饭后2小时)口服25~75mg/d,若最大剂量应用4周无效常推荐停用[2]。

作者孙维栋余醒醒安依涵王鑫王莹童向民

机构地区浙江绍兴市中心医院血液风湿科蚌埠医学院研究生院浙江省人民医院肿瘤分子诊断与个体化研究室重点实验室

出处《中国乡村医药》 2020年第5期49-50,共2页

关键词美国食品药品监督管理局常规用法一线治疗药物原发性免疫性血小板减少症糖皮质激素脾切除免疫球蛋白艾曲波帕

分类号 R558.2 [医药卫生—血液循环系统疾病]

引文网络
相关文献

参考文献1

1董志高,陈旭艳.难治性ITP的发病机制和现代免疫治疗[J].中国老年保健医学,2010,8(5):60-62. 被引量：9

二级参考文献25

1Kappers-Klunne MC,van't Veer MB.Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytomenic purpura refractory to cortiscosteroid or splenectomy[J].Br J Haematol,2001,114:121-125.
2Stasi R,Pagano A,Stipa E,et al.Rituximab chimeric anti-CD20 monoClonal antibody treatment for aduts with chronic idiopathic thrombocytopenic purpura[J].Blood,2001,98:952-957.
3Melinda CH,Bruce HP.Detection of platelet-associated immunoglobulin in immune thrombocytopenia by flow cytomery[J].Diagn Clin Immunol,1988,5:309.
4Stockelberg D,Hou M,Jacobsson S,et al.Detection of platelet antibodies in chronic thrombocytopenia purpura(ITP).A comparative study using flow cytometry,a whole platelet ELISA,and an antigen capture ELISA[J] Eur J Haematol,1996,56:74.
5Vainchenker W,Deschamps JF,Bastin JM,et al Two monoclonal antiplatelet antibodies as markersof human megakaryocyte maturation:immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients[J].Blood,1982,59:514-521.
6Garcia 2 Suarez J,Prieto A,Reyes E,et al.The clinical outcome of autoimmune thombocytopenic prupura patients is related te their all immunodeficiency[J].Br J Haematol,1993,84,464.
7Olsson B,Andersson PO,Jernas M,et al.T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura[J].Nat Med,2003,9:1123-1124.
8Emilia G,Morselli M,Luppi M,et al.Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura[J].Blood.2002,99:1482-1485.
9Crossley AR,Dickinson AM,Proctor SJ,et al.Effects of interferon alpha therapy on immune parameters in immune thrombocytopenic purpura[J].Autoimmunity,1996,24(2):81-100.
10Proctor SJ,Jackson B,Carey P.et al.Improvement platecet counts in steroid unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant α-2a interferon[J].Blood,1989,74(6):1894.